Back
BridgeBio Pharma Stock Price Chart

AI Marketing Is Moving Fast–Don't Miss Your Window!
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
Sell
28
BBIO
BridgeBio Pharma
Last Price:
$33.03
Seasonality Move:
1.07%
7 Day Trial
ALL ACCESS PASS
$
7

AI Is Disrupting Marketing—Invest Before April 10!
⏳ Secure Your Stake in AI Marketing Before This Window Closes!-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBIO is experiencing selling pressure, which indicates risk of future bearish movement.
BridgeBio Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.5 | Sell |
20-day SMA: | 33.97 | Sell |
50-day SMA: | 34.25 | Sell |
200-day SMA: | 28.34 | Buy |
8-day EMA: | 34.7 | Sell |
20-day EMA: | 34.4 | Sell |
50-day EMA: | 33.38 | Sell |
200-day EMA: | 29.88 | Buy |
BridgeBio Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.4 | Buy |
Relative Strength Index (14 RSI): | 45.09 | Sell |
Chaikin Money Flow: | -2384935 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.46 - 35.48) | Sell |
Bollinger Bands (100): | (26.48 - 34.92) | Buy |
BridgeBio Pharma Technical Analysis
Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BridgeBio Pharma Stock
Is BridgeBio Pharma Stock a Buy?
-
BridgeBio Pharma share price is 33.02 while BBIO 8-day simple moving average is 35.50, which is a Sell signal.
-
The stock price of BBIO is 33.02 while BridgeBio Pharma 20-day SMA is 33.97, which makes it a Sell.
-
BridgeBio Pharma 50-day simple moving average is 34.25 while BBIO share price is 33.02, making it a Sell technically.
-
BBIO stock price is 33.02 and BridgeBio Pharma 200-day simple moving average is 28.34, creating a Buy signal.
BBIO Technical Analysis vs Fundamental Analysis
Sell
28
BridgeBio Pharma (BBIO)
is a Sell
Is BridgeBio Pharma a Buy or a Sell?
-
BridgeBio Pharma stock is rated a SellThe current BridgeBio Pharma [BBIO] share price is $33.02. The Score for BBIO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
BridgeBio Pharma Stock Info
Market Cap:
6.3B
Price in USD:
33.02
Share Volume:
3M
BridgeBio Pharma 52-Week Range
52-Week High:
39.47
52-Week Low:
21.62
Sell
28
BridgeBio Pharma (BBIO)
is a Sell
BridgeBio Pharma Share Price Forecast
-
What is the BridgeBio Pharma stock price today?The BridgeBio Pharma stock price is 33.02 USD today.
-
Will BBIO stock go up or go down?BridgeBio Pharma> share price is forecast to RISE/FALL based on technical indicators
-
Is BridgeBio Pharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BridgeBio Pharma is overvalued.
Is BridgeBio Pharma Stock a Buy?
-
BridgeBio Pharma share price is 33.02 while BBIO 8-day exponential moving average is 34.70, which is a Sell signal.
-
The stock price of BBIO is 33.02 while BridgeBio Pharma 20-day EMA is 34.40, which makes it a Sell.
-
BridgeBio Pharma 50-day exponential moving average is 33.38 while BBIO share price is 33.02, making it a Sell technically.
-
BBIO stock price is 33.02 and BridgeBio Pharma 200-day simple moving average is 29.88, creating a Buy signal.
Fundamental Analysis of BridgeBio Pharma
Is BridgeBio Pharma a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.05 per share, a decrease this year of $1.15 per share, and an increase next year of $0.70 per share.
Technical Analysis of BridgeBio Pharma
Should I short BridgeBio Pharma stock?
-
BBIO Moving Average Covergence Divergence (MACD) indicator is 0.4, suggesting BridgeBio Pharma is a Buy
-
BridgeBio Pharma Relative Strength Index (RSI) is 45.09, which suggest BridgeBio Pharma is oversold
-
The Bollinger Bands (25) for BridgeBio Pharma is (32.46 - 35.48), which suggest BridgeBio Pharma is a Buy
-
The Bollinger Bands (100) for BridgeBio Pharma is (26.48 - 34.92), which suggest BridgeBio Pharma is a Buy
* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.